| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 3356-3364, Copyright © 1992 by Endocrine Society
ARTICLES |
A Sjoberg, J Oscarsson, K Bostrom, TL Innerarity, S Eden and SO Olofsson
Department of Medical Biochemistry, University of Goteborg, Sweden.
Apolipoprotein-B 48 (apoB 48) and apoB 100 expression and the editing of apoB mRNA have previously been shown to be hormonally regulated in rat liver. We have investigated the effects of hypophysectomy and replacement therapy with T4, cortisol (C), and GH in vivo on the proportion of edited apoB mRNA in rat liver and cultured rat hepatocytes as well as the synthesis and secretion of apoB 48 and apoB 100 in cultured rat hepatocytes. Hypophysectomy decreased the proportion of edited apoB mRNA in intact liver from 62% in normal rats to 29% in hypophysectomized rats. Treatment of hypophysectomized rats with T4 and C did not influence the proportion of edited apoB mRNA, whereas treatment with GH, either alone or together with T4 and C, increased the proportion of edited apoB mRNA to the levels observed in normal rats. In cultured hepatocytes isolated from normal rats, the proportion of apoB 48 (percentage of total labeled apoB) was 78% and decreased to 40% in cells isolated from hypophysectomized rats. Treatment of hypophysectomized rats with T4 and C had no effect on the proportion of apoB 48 present in isolated cells, whereas it increased to 60% after treatment with GH together with T4 and C. The proportion of apoB 48 in the medium was affected by hypophysectomy and the various hormonal treatments in a similar way to that observed in the cells. Results from in vivo labeling experiments suggested that GH alone had the capacity to increase the percentage of apoB 48 in hypophysectomized rats. On the contrary, T4 and C was needed, in addition to GH, to increase the proportion of apoB 48 in isolated hepatocytes from hypophysectomized rats. Our results suggest that this discrepancy is due to a difference between the effect of GH alone on apoB mRNA editing in the intact liver and that in isolated hepatocytes. The total secretion of apoB into the cell culture medium was not affected by hypophysectomy and hormonal treatments of the rats. In conclusion, these results indicate that GH is involved in the regulation of editing of apoB mRNA and the proportion of apoB 48 synthesized and secreted in rat liver. Thus, our observations emphasize the importance of GH as a regulator of lipoprotein metabolism.
This article has been cited by other articles:
![]() |
U. Edvardsson, A. Ljungberg, D. Linden, L. William-Olsson, H. Peilot-Sjogren, A. Ahnmark, and J. Oscarsson PPAR{alpha} activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes J. Lipid Res., February 1, 2006; 47(2): 329 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ameen, U. Edvardsson, A. Ljungberg, L. Asp, P. Akerblad, A. Tuneld, S.-O. Olofsson, D. Linden, and J. Oscarsson Activation of Peroxisome Proliferator-activated Receptor {alpha} Increases the Expression and Activity of Microsomal Triglyceride Transfer Protein in the Liver J. Biol. Chem., January 14, 2005; 280(2): 1224 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stillemark-Billton, C. Beck, J. Boren, and S.-O. Olofsson Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2 J. Lipid Res., January 1, 2005; 46(1): 104 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lind, M. Rudling, S. Ericsson, H. Olivecrona, M. Eriksson, B. Borgstrom, G. Eggertsen, L. Berglund, and B. Angelin Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 349 - 356. [Abstract] [Full Text] |
||||
![]() |
C. Ameen and J. Oscarsson Sex Difference in Hepatic Microsomal Triglyceride Transfer Protein Expression Is Determined by the Growth Hormone Secretory Pattern in the Rat Endocrinology, September 1, 2003; 144(9): 3914 - 3921. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Patterson, Z. Chen, D. C. Rubin, V. Moucadel, J. L. Iovanna, H. B. Brewer Jr., and T. L. Eggerman Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1 J. Biol. Chem., February 21, 2003; 278(9): 7600 - 7606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jalouli, L. Carlsson, C. Ameen, D. Linden, A. Ljungberg, L. Michalik, S. Eden, W. Wahli, and J. Oscarsson Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor {alpha} Expression: Influence of Pituitary and Gonadal Hormones Endocrinology, January 1, 2003; 144(1): 101 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frick, D. Linden, C. Ameen, S. Eden, A. Mode, and J. Oscarsson Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1023 - E1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frick, M. Bohlooly-Y, D. Linden, B. Olsson, J. Tornell, S. Eden, and J. Oscarsson Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1230 - E1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Linden, M. Alsterholm, H. Wennbo, and J. Oscarsson PPAR{alpha} deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins J. Lipid Res., November 1, 2001; 42(11): 1831 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Carlsson, D. Linden, M. Jalouli, and J. Oscarsson Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPAR{alpha} in rat liver Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E772 - E781. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. RUDLING and B. ANGELIN Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice FASEB J, June 1, 2001; 15(8): 1350 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Oscarsson, C. Gardmo, S. Eden, and A. Mode Pulsatile growth hormone secretion decreases S-adenosylmethionine synthetase in rat liver Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E280 - E286. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Linden, A. Sjoberg, L. Asp, L. Carlsson, and J. Oscarsson Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1335 - E1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, J.-F. Beaulieu, E. Delvin, E. Seidman, W. Yotov, J.-R. Basque, and D. Ménard Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly J. Lipid Res., January 1, 2000; 41(1): 12 - 22. [Abstract] [Full Text] |
||||
![]() |
J. Svensson, J.-O. Jansson, M. Ottosson, G. Johannsson, M.-R. Taskinen, O. Wiklund, and B.-A. Bengtsson Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a) J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2028 - 2033. [Abstract] [Full Text] |
||||
![]() |
M. Leonsson, J. Oscarsson, I. Bosaeus, B. K. Lundgren, G. Johannsson, O. Wiklund, and B. A. Bengtsson Growth Hormone (GH) Therapy in GH-Deficient Adults Influences the Response to a Dietary Load of Cholesterol and Saturated Fat in Terms of Cholesterol Synthesis, But Not Serum Low Density Lipoprotein Cholesterol Levels J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1296 - 1303. [Abstract] [Full Text] |
||||
![]() |
P. Parini, B. Angelin, and M. Rudling Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Greeve, D. Axelos, S. Welker, M. Schipper, and H. Greten Distinct Promoters Induce APOBEC-1 Expression in Rat Liver and Intestine Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1079 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Carlsson, I. Nilsson, and J. Oscarsson Hormonal Regulation of Liver Fatty Acid-Binding Protein in Vivo and in Vitro: Effects of Growth Hormone and Insulin Endocrinology, June 1, 1998; 139(6): 2699 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Ceda, E. DallAglio, A. Magnacavallo, N. Vargas, V. Fontana, M. Maggio, G. Valenti, P. D. K. Lee, R. L. Hintz, and A. R. Hoffman The Insulin-Like Growth Factor Axis and Plasma Lipid Levels in the Elderly J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 499 - 502. [Abstract] [Full Text] |
||||
![]() |
T. L. Innerarity, J. Borén, S. Yamanaka, and S.-O. Olofsson Biosynthesis of Apolipoprotein B48-containing Lipoproteins J. Biol. Chem., February 2, 1996; 271(5): 2353 - 2356. [Full Text] [PDF] |
||||
![]() |
C.-N. Wang, R. S. McLeod, Z. Yao, and D. N. Brindley Effects of Dexamethasone on the Synthesis, Degradation, and Secretion of Apolipoprotein B in Cultured Rat Hepatocytes Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1481 - 1491. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |